Federal fact file dated September 26, 2026.
Ask what the exact product is approved to do
Ask for the name, how it would be given and what it would treat. An approval for one product does not cover a whole menu.
Separate the approval questions
Approval has a scope
FDA has approved products with semaglutide (Ozempic, Wegovy).
Read the FDA label for semaglutide (Wegovy)
Products with tirzepatide (Mounjaro, Zepbound) also have FDA approval for named uses.
Read the FDA label for tirzepatide (Mounjaro)
Get the exact name and how the medicine would be given. Ask what the product is approved to treat. Then ask if that matches the use being proposed.
A known name can still lack approval
At the dated FDA records check, neither BPC-157 nor ipamorelin had U.S. approval.
Inspect the FDA application-record source
That answers a U.S. approval question. It does not settle the separate rules for compounding.
When a medicine is prepared to order, that is called compounding.
If you are offered a named peptide, ask for its own approval record. An answer about another medicine leaves your question open.
Medicine prepared to order needs its own questions
Compounded drugs have no FDA approval, even when an ingredient is also used in an approved product.
Read why compounded preparations lack FDA approval
Ask for the label. Ask for the pharmacy name. Ask for the reason the medicine fits your health problem. Each answer serves a different purpose.